Purchase Order 75D30123P17506
Award Date
8/25/23
Potential Completion Date
4/30/24
Potential Value
$51K
Federal Agency
CDC Pittsburgh
Awardee
Twist Bioscience Corporation
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This $363,754.94 firm fixed price purchase order from the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) was awarded to Twist Bioscience Corporation, a synthetic biology company, to provide SC2 POSITIVE CONTROL SYNTHETIC RNA CONTROL. The contract does not have a set-aside designation. Twist Bioscience is a for-profit manufacturer based in South San Francisco, California that develops custom oligonucleotides, gene panels, and other synthetic biology...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $157,390 firm fixed price purchase order contract to Twist Bioscience Corporation for the delivery of "LAP SUPPLIES." This contract, which has a completion date of September 14, 2025, does not include a set-aside designation. Twist Bioscience is a synthetic biology company that specializes in the manufacture of high-quality synthetic DNA products and services. Through this contract, Twist Bioscience will likely provide...
This federal contract award was issued by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Twist Bioscience Corporation, a for-profit synthetic biology company based in South San Francisco, California. The $125,565.50 firm fixed price purchase order is for the delivery of SARS COV2 RNA control products to support COVID-19 research and diagnostics efforts. The contract does not have a set-aside designation. Twist Bioscience provides various...
The Department of Health and Human Services Centers for Disease Control and Prevention (HHS CDC) awarded a firm fixed price purchase order contract to Twist Bioscience Corporation, a synthetic biology company based in South San Francisco, California. The $220,065.50 contract is for the provision of SARS COV 2 RNA controls to support COVID-19 research efforts. Twist Bioscience, as a prime contractor, has provided various research products to federal agencies including the NIH, VA, and...
This is a federal contract award to Twist Bioscience Corporation, a synthetic biology company based in South San Francisco, California, for the provision of SARS-CoV-2 RNA controls. The contract, valued at $82,080.66, was awarded by the Centers for Disease Control and Prevention (CDC) on July 29, 2020 and has an ultimate completion date of August 29, 2020. The contract is a firm fixed price purchase order and does not have a set-aside designation. Twist Bioscience has been a key provider of...
This is a firm fixed price purchase order contract awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Twist Bioscience Corporation, a for-profit synthetic biology company based in South San Francisco, California. The contract is for the provision of biological and reagent materials, with a ceiling value of $12,206.25 and a period of performance through September 4, 2025. There is no set-aside designation for this...
This is a firm fixed price purchase order valued at $22,400.00 awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Twist Bioscience Corporation for DNA synthesis services to support gene cloning. The contract has no set-aside designation and the ultimate completion date is December 31, 2024. Twist Bioscience is a synthetic biology company that specializes in manufacturing high-quality synthetic DNA and has...
This federal contract award to Twist Bioscience Corporation, a synthetic biology company in South San Francisco, CA, is for the delivery of COVID-19 DNA constructs. The $29,671.85 firm fixed price purchase order was awarded on June 4, 2020 by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the National Institutes of Health (NIH). The contract does not have a set-aside designation. Through this award, as well as previous contracts and grants, Twist...
This is a $14,031.25 firm fixed price purchase order awarded by the National Human Genome Research Institute (NHGRI) to Twist Bioscience Corporation, a synthetic biology company based in South San Francisco, California. The contract is for Twist Bioscience to provide a custom capture panel to support a new blood-based cancer diagnostic that will detect human herpesvirus 8 (HHV8) in the plasma of HIV patients. The award has an ultimate completion date of October 31, 2024 and was made on August...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a firm fixed price purchase order valued at $15,117.00 to Twist Bioscience Corporation, a synthetic biology company based in South San Francisco, California. The contract is for the delivery of a TWIST Library Preparation Kit 1. This award does not have a set-aside designation. Twist Bioscience is a prime contractor on this purchase order, which has an ultimate completion date of October 14, 2024. The company...